Bristol Myers Squibb SEC filings: 8-K

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KOct. 29, 2026, 7:05 a.m. ETView on SEC.gov Our explainer
Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewedBristol Myers Squibb beats Q3 2026 non-GAAP EPS at $1.35 vs $1.22 consensus and raises revenue guidance, but cuts full-year EPS outlook to $6.35 to $6.55 on $0.60 acquired IPRD charges
8-KJuly 30, 2026, 7:05 a.m. ETView on SEC.gov
Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits